Zolpidem abuse, dependence and withdrawal syndrome: Sex as susceptibility factor for adverse effects

British Journal of Clinical Pharmacology

Volumn 65, Issue 3, 2008, Pages 444-445

  Cubała, Wiesław J ^a   Landowski, Jerzy ^a   Wichowicz, Hubert M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIGESTAGEN; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEINASE INHIBITOR; PROTON PUMP INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SEX HORMONE; STEROID; TRIPTAN DERIVATIVE; ZOLPIDEM;

DRUG ABUSE; DRUG BINDING; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG SENSITIVITY; HUMAN; LETTER; PRIORITY JOURNAL; SEX DIFFERENCE; WITHDRAWAL SYNDROME;

FEMALE; HUMANS; MALE; PYRIDINES; SEX CHARACTERISTICS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 39849099803     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03028.x     Document Type: Letter

References (10)

1. Olubodun JO, Ochs HR, von Moltke LL, Roubenoff R, Hesse LM, Harmatz JS, Shader RI, Greenblatt DJ. Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. Br J Clin Pharmacol 2003 56 : 297 304.
2. Huang MC, Lin HY, Chen CH. Dependence on zolpidem. Psychiatry Clin Neurosci 2007 61 : 207 8.
3. Cubala WJ, Landowski J. Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 2007 31 : 539 40.
4. Hajak G, Müller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003 98 : 1371 8.
5. Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, Harmatz JS, Shader RI. Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. Br J Clin Pharmacol 1999 48 : 89 97.
6. Cozza KL, Armstrong SC, Oesterheld JR. Concise Guide to Drug Interaction Principles for Medical Practice. Washington DC : APPI, 2003.
7. Olubodun JO, Ochs HR, Trüten V, Klein A, von Moltke LL, Harmatz JS, Shader RI, Greenblatt DJ. Zolpidem pharmacokinetic properties in young females: influence of smoking and oral contraceptive use. J Clin Pharmacol 2002 42 : 1142 6.
8. Pacifici GM, Viani A, Rizzo G, Carrai M, Ganansia J, Bianchetti G, Morselli PL. Plasma protein binding of zolpidem in liver and renal insufficiency. Int J Pharmacol Ther Toxicol 1988 26 : 439 43.
9. Tripodianakis J, Potagas C, Papageorgiou P, Lazaridou M, Matikas N. Zolpidem-related epileptic seizures: a case report. Eur Psychiatry 2003 18 : 140 1.
10. Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, Durol AL, Harrel-Joseph LM, Shader RI. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. J Pharmacol Exp Ther 2000 293 : 435 43.